U.S. Equity Market Outperformance

U.S. Equity Market Outperformance According to Gavekal, U.S. outperformance is mainly cyclical, not structural, and best investment opportunities could be in non-US assets. Image: Gavekal, Macrobond

Indexed Market Cap and Consensus Fwd 12m EPS Estimates for S&P 500 Companies

Indexed Market Cap and Consensus Fwd 12m EPS Estimates for S&P 500 Companies Earnings momentum is driving the AI infrastructure complex’s outperformance so far this year, with capital flowing to names that are already translating AI demand into visible revenue growth, order strength, and profit expansion. Image: Goldman Sachs Global Investment Research

Performance vs. S&P 500 by Uses of Cash

Performance vs. S&P 500 by Uses of Cash U.S. companies that return the most cash to shareholders through dividends and buybacks have outperformed the S&P 500 since 1992. The outperformance usually reflects stronger fundamentals and disciplined capital allocation. Image: Goldman Sachs Global Investment Research

Global Equities Performance

Global Equities Performance Since spring 2025, U.S. stocks have underperformed relative to other major markets, breaking a long streak of outperformance. A weaker dollar has added momentum to global diversification, especially among overseas investors. Image: Goldman Sachs Global Investment Research

Nasdaq 100 to S&P 500 Valuation Spread

Nasdaq 100 to S&P 500 Valuation Spread The last time the Nasdaq 100 traded this cheap versus the S&P 500, it staged its biggest outperformance in a year. Honestly, that’s tough to ignore. Image: Bloomberg

Gold to S&P 500 Ratio

Gold to S&P 500 Ratio Gold’s outperformance has pushed the Gold-to-S&P 500 ratio to its highest since 2013, signaling a defensive shift but not yet the kind of rush to safety seen during crisis years. Image: Goldman Sachs Global Investment Research

MSCI Equity Indexes, Total Return in US$

MSCI Equity Indexes, Total Return in US$ America’s equity outperformance topped out in 2022. U.S. growth still looks solid, but lofty valuations suggest tougher performance ahead, arguing for a more balanced global allocation in 2026. Image: Gavekal, Macrobond